Page 108«..1020..107108109110..120130..»

SpaceX To Launch NG-20 To ISS On Tuesday (updated) – Talk of Titusville

Posted: Published on January 27th, 2024

A Northrup Grumman Cygnus at the International Space Station Photo courtesy of Northrup Grumman On Monday, January 29th, update: Tuesday, January 30th SpaceX will launch Northrup-Grummans Cygnus CRS-2 towards the International Space Station aboard a Falcon 9. This launch will be the 20th resupply mission carried out as part of NGs Commercial Resupply contract with NASA, and will ferry supplies for the stations crew, equipment, as well as new scientific experiments to the orbiting outpost. The launch is scheduled for 12:07 PM EST with an instantaneous window from Cape Canaverals SLC-40. Continue reading →

Posted in Spacex | Comments Off on SpaceX To Launch NG-20 To ISS On Tuesday (updated) – Talk of Titusville

John Deere & SpaceX and Mexican GM Corn Ban – AG INFORMATION NETWORK OF THE WEST – AGInfo Ag Information Network

Posted: Published on January 27th, 2024

From the Ag Information Network, Im Bob Larson with your Agribusiness Update. Continue reading →

Posted in Spacex | Comments Off on John Deere & SpaceX and Mexican GM Corn Ban – AG INFORMATION NETWORK OF THE WEST – AGInfo Ag Information Network

Enhanced Macrophages Developed to Decrease Inflammation in Traumatic Brain Injury – MedicalResearch.com

Posted: Published on January 19th, 2024

MedicalResearch.com Interview with: Samir Mitragotri Ph.D. Hiller Professor of Bioengineering Hansjorg Wyss Professor of Biologically Inspired Engineering Area Chair, Bioengineering Core Faculty Member, Wyss Institute for Biologically Inspired Engineering Harvard John A. Continue reading →

Posted in Brain Injury Treatment | Comments Off on Enhanced Macrophages Developed to Decrease Inflammation in Traumatic Brain Injury – MedicalResearch.com

Reversing Memory Loss Due to Repeated Head Impacts: New Insights from a Mouse Study – Medriva

Posted: Published on January 19th, 2024

A recent groundbreaking study conducted by researchers at Georgetown University Medical Center and Trinity College Dublin offers new hope in the understanding and potential treatment of memory loss caused by repeated head impacts. This research, supported by the Mouse Behavior Core in the Georgetown University Neuroscience Department and by grants from the National Institutes of Health (NIH) and the National Institute of Neurological Disorders and Stroke (NINDS), has significant implications for those suffering from cognitive impairments due to head injuries. The study suggests that memory loss caused by repeated head impacts may potentially be reversed. Continue reading →

Posted in Brain Injury Treatment | Comments Off on Reversing Memory Loss Due to Repeated Head Impacts: New Insights from a Mouse Study – Medriva

Memory Loss after Head Injury: A Reversible Condition? – Medriva

Posted: Published on January 19th, 2024

Memory Loss after Head Injury: A Reversible Condition? Memory loss due to repeated head injuries has long been a significant concern, particularly for athletes and those involved in high-impact activities Continue reading →

Posted in Brain Injury Treatment | Comments Off on Memory Loss after Head Injury: A Reversible Condition? – Medriva

Amnesia and memory loss from head injuries reversed – Study Finds

Posted: Published on January 19th, 2024

Key Findings: WASHINGTON Could a cure for brain injuries be on the horizon? Researchers at Georgetown University Medical Center and Trinity College Dublin suggest that science could potentially reverse memory loss due to repeated head impacts, a common problem among athletes in sports like football. The study reveals that amnesia and poor memory following a head injury may be the result of an inadequate reactivation of neurons connected to forming memories Continue reading →

Posted in Brain Injury Treatment | Comments Off on Amnesia and memory loss from head injuries reversed – Study Finds

Wounded Warrior Project Invests $100 Million More in Mental Health and Brain Injury Care – InvestorsObserver

Posted: Published on January 19th, 2024

2-week treatment beats traditional therapy for PTSD JACKSONVILLE, Fla. , Jan. 16, 2024 /PRNewswire/ -- Wounded Warrior Project (WWP) is investing over $100 million in evidence-based care for veteran mental health and brain injuries. Continue reading →

Posted in Brain Injury Treatment | Comments Off on Wounded Warrior Project Invests $100 Million More in Mental Health and Brain Injury Care – InvestorsObserver

UTHealth Houston’s Trial Shows Promising Outcomes Using Bone Marrow Cells for Pediatric Brain Injury – BNN Breaking

Posted: Published on January 19th, 2024

UTHealth Houstons Trial Shows Promising Outcomes Using Bone Marrow Cells for Pediatric Brain Injury Severe traumatic brain injury (TBI) in children, a leading cause of death and disability, may have met its match. A recent Phase II clinical trial led by Charles S. Cox Jr., MD, and Linda Ewing-Cobbs, PhD, from UTHealth Houston, has revealed encouraging results. Continue reading →

Posted in Brain Injury Treatment | Comments Off on UTHealth Houston’s Trial Shows Promising Outcomes Using Bone Marrow Cells for Pediatric Brain Injury – BNN Breaking

Bioengineered approach shows promise in ulcerative colitis: Newsroom – UT Southwestern, Dallas, Texas – UT Southwestern

Posted: Published on January 19th, 2024

(Photo credit: Getty Images) DALLAS Jan. 16, 2024 By taking advantage of mechanisms that allow cancer cells to evade immune attack, UTSouthwestern Medical Center researchers have developed a new strategy in animal models that has potential for treating ulcerative colitis. Their findings, reported in Nature Biomedical Engineering, could eventually provide relief to millions of people worldwide who have this or other autoimmune conditions Continue reading →

Posted in Ulcerative Colitis | Comments Off on Bioengineered approach shows promise in ulcerative colitis: Newsroom – UT Southwestern, Dallas, Texas – UT Southwestern

UNIFI Long-Term Extension Shows Safety, Efficacy of Ustekinumab for Ulcerative Colitis Through 4 Years – MD Magazine

Posted: Published on January 19th, 2024

Waqqas Afif, MD Credit: McGill University Long-term subcutaneous maintenance therapy with ustekinumab every 8 and 12 weeks can maintain clinical and endoscopic outcomes through 4 years, according to the final efficacy and safety results of the UNIFI long-term extension study in patients with ulcerative colitis (UC). In patients who responded to intravenous ustekinumab induction, therapy was safe and effective at maintaining symptomatic remission, providing clinical and endoscopic benefit to patients through 4 years of treatment without the need for concomitant corticosteroids and with no new safety signals reported.1 Due to the life-long nature of UC, long-term treatment is often required to induce and maintain remission Continue reading →

Posted in Ulcerative Colitis | Comments Off on UNIFI Long-Term Extension Shows Safety, Efficacy of Ustekinumab for Ulcerative Colitis Through 4 Years – MD Magazine

Page 108«..1020..107108109110..120130..»